Paper222124
Adenylate cyclase assay.
Salomon Y. Adv Cyclic Nucleotide Res, 1979. Cited by 462 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Adenylate cyclase assay. Papers, record 222124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/222124
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenylyl Cyclases | Major topic |
| Adenosine Triphosphate | |
| Animals | |
| Chromatography | |
| Cyclic AMP | |
| Methods | |
| Phosphorus Radioisotopes | |
| Tritium |
Source PubMed
Cited by125
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 462 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,197,733 | Biochemical characterization of the full-length isoform of soluble adenylyl cyclase. | J Biol Chem | 2025 | https://conductscience.org/library/papers/41197733 | PubMed |
| 40,650,178 | Updating the Mechanism of Bicarbonate (HCO3-) Activation of Soluble Adenylyl Cyclase (sAC). | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650178 | PubMed |
| 37,097,314 | Carbonic Anhydrase Inhibitor Modulation of Intraocular Pressure Is Independent of Soluble Adenylyl Cyclase. | J Ocul Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37097314 | PubMed |
| 37,060,320 | Scaffold Hopping and Optimization of Small Molecule Soluble Adenyl Cyclase Inhibitors Led by Free Energy Perturbation. | J Chem Inf Model | 2023 | https://conductscience.org/library/papers/37060320 | PubMed |
| 36,788,210 | On-demand male contraception via acute inhibition of soluble adenylyl cyclase. | Nat Commun | 2023 | https://conductscience.org/library/papers/36788210 | PubMed |
| 36,346,696 | Design, Synthesis, and Pharmacological Evaluation of Second-Generation Soluble Adenylyl Cyclase (sAC, ADCY10) Inhibitors with Slow Dissociation Rates. | J Med Chem | 2022 | https://conductscience.org/library/papers/36346696 | PubMed |
| 36,246,105 | Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential. | Front Physiol | 2022 | https://conductscience.org/library/papers/36246105 | PubMed |
| 27,912,212 | Knockdown of Inhibitory Guanine Nucleotide Binding Protein Giα-2 by Antisense Oligodeoxynucleotides Attenuates the Development of Hypertension and Tachycardia in Spontaneously Hypertensive Rats. | J Am Heart Assoc | 2016 | https://conductscience.org/library/papers/27912212 | PubMed |
| 27,547,922 | Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase. | Nat Chem Biol | 2016 | https://conductscience.org/library/papers/27547922 | PubMed |
| 24,633,354 | Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39. | Nat Chem Biol | 2014 | https://conductscience.org/library/papers/24633354 | PubMed |
| 24,567,411 | Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24567411 | PubMed |
| 24,091,307 | Pharmacological distinction between soluble and transmembrane adenylyl cyclases. | J Pharmacol Exp Ther | 2013 | https://conductscience.org/library/papers/24091307 | PubMed |
| 23,587,004 | Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes. | Br J Pharmacol | 2013 | https://conductscience.org/library/papers/23587004 | PubMed |
| 23,459,251 | High adenylyl cyclase activity and in vivo cAMP fluctuations in corals suggest central physiological role. | Sci Rep | 2013 | https://conductscience.org/library/papers/23459251 | PubMed |
| 22,815,884 | R-Spondin potentiates Wnt/β-catenin signaling through orphan receptors LGR4 and LGR5. | PLoS One | 2012 | https://conductscience.org/library/papers/22815884 | PubMed |
| 22,761,895 | Characterization of Plasmodium falciparum adenylyl cyclase-β and its role in erythrocytic stage parasites. | PLoS One | 2012 | https://conductscience.org/library/papers/22761895 | PubMed |
| 22,504,007 | Novel approach for generation of low calcium reagents for investigations of heavy metal effects on calcium signaling. | J Pharmacol Toxicol Methods | 2012 | https://conductscience.org/library/papers/22504007 | PubMed |
| 21,907,220 | Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens. | Neuropharmacology | 2011 | https://conductscience.org/library/papers/21907220 | PubMed |
| 21,559,804 | delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory. | Psychopharmacology (Berl) | 2011 | https://conductscience.org/library/papers/21559804 | PubMed |
| 19,996,298 | Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound. | J Pharmacol Exp Ther | 2010 | https://conductscience.org/library/papers/19996298 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/222124
GET https://conductscience.org/api/papers/v1/222124/cited_by?page=2